442 related articles for article (PubMed ID: 14983108)
1. SAPHO syndrome treated with pamidronate: an open-label study of 10 patients.
Amital H; Applbaum YH; Aamar S; Daniel N; Rubinow A
Rheumatology (Oxford); 2004 May; 43(5):658-61. PubMed ID: 14983108
[TBL] [Abstract][Full Text] [Related]
2. Pamidronate in the treatment of childhood SAPHO syndrome.
Kerrison C; Davidson JE; Cleary AG; Beresford MW
Rheumatology (Oxford); 2004 Oct; 43(10):1246-51. PubMed ID: 15238641
[TBL] [Abstract][Full Text] [Related]
3. In SAPHO syndrome anti-TNF-alpha therapy may induce persistent amelioration of osteoarticular complaints, but may exacerbate cutaneous manifestations.
Massara A; Cavazzini PL; Trotta F
Rheumatology (Oxford); 2006 Jun; 45(6):730-3. PubMed ID: 16403830
[TBL] [Abstract][Full Text] [Related]
4. Acne fulminans with synovitis-acne-pustulosis-hyperostosis-osteitis (SAPHO) syndrome treated with infliximab.
Iqbal M; Kolodney MS
J Am Acad Dermatol; 2005 May; 52(5 Suppl 1):S118-20. PubMed ID: 15858507
[TBL] [Abstract][Full Text] [Related]
5. Ilium osteitis as the main manifestation of the SAPHO syndrome: response to infliximab therapy and review of the literature.
Moll C; Hernández MV; Cañete JD; Gómez-Puerta JA; Soriano A; Collado A; Sanmartí R
Semin Arthritis Rheum; 2008 Apr; 37(5):299-306. PubMed ID: 17976692
[TBL] [Abstract][Full Text] [Related]
6. Sustained remission of SAPHO syndrome with pamidronate: a follow-up of fourteen cases and a review of the literature.
Colina M; La Corte R; Trotta F
Clin Exp Rheumatol; 2009; 27(1):112-5. PubMed ID: 19327238
[TBL] [Abstract][Full Text] [Related]
7. The usefulness of bone remodelling markers in predicting the efficacy of pamidronate treatment in SAPHO syndrome.
Solau-Gervais E; Soubrier M; Gerot I; Grange L; Puechal X; Sordet C; Sibilia J; Duquesnoy B
Rheumatology (Oxford); 2006 Mar; 45(3):339-42. PubMed ID: 16249241
[TBL] [Abstract][Full Text] [Related]
8. Synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome treated with a combination of isotretinoin and pamidronate.
Galadari H; Bishop AG; Venna SS; Sultan E; Do D; Zeltser R
J Am Acad Dermatol; 2009 Jul; 61(1):123-5. PubMed ID: 19539848
[TBL] [Abstract][Full Text] [Related]
9. SAPHO: rare or just not recognized?
Van Doornum S; Barraclough D; McColl G; Wicks I
Semin Arthritis Rheum; 2000 Aug; 30(1):70-7. PubMed ID: 10966214
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment of primary chronic osteomyelitis in SAPHO syndrome with bisphosphonates.
Just A; Adams S; Brinkmeier T; Barsegian V; Lorenzen J; Schilling F; Frosch P
J Dtsch Dermatol Ges; 2008 Aug; 6(8):657-60. PubMed ID: 18266863
[TBL] [Abstract][Full Text] [Related]
11. SAPHO syndrome in childhood. A case report.
Vargas Pérez M; Sevilla Pérez B
Reumatol Clin (Engl Ed); 2018; 14(2):109-112. PubMed ID: 27993538
[TBL] [Abstract][Full Text] [Related]
12. Chronic recurrent multifocal osteomyelitis (CRMO) and synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome with associated neutrophilic dermatoses: a report of seven cases and review of the literature.
Tlougan BE; Podjasek JO; O'Haver J; Cordova KB; Nguyen XH; Tee R; Pinckard-Hansen KC; Hansen RC
Pediatr Dermatol; 2009; 26(5):497-505. PubMed ID: 19840301
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the immune response in the synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO) syndrome.
Hurtado-Nedelec M; Chollet-Martin S; Nicaise-Roland P; Grootenboer-Mignot S; Ruimy R; Meyer O; Hayem G
Rheumatology (Oxford); 2008 Aug; 47(8):1160-7. PubMed ID: 18559374
[TBL] [Abstract][Full Text] [Related]
14. [SAPHO syndrome and aseptic osteitis].
Cotten A; Boutry N; Demondion X; Chastanet P; Flipo RM
Ann Radiol (Paris); 1997; 40(3):189-96. PubMed ID: 9810077
[TBL] [Abstract][Full Text] [Related]
15. The SAPHO syndrome: a single-center study of 41 adult patients.
Aljuhani F; Tournadre A; Tatar Z; Couderc M; Mathieu S; Malochet-Guinamand S; Soubrier M; Dubost JJ
J Rheumatol; 2015 Feb; 42(2):329-34. PubMed ID: 25512472
[TBL] [Abstract][Full Text] [Related]
16. SAPHO syndrome associated with hidradenitis suppurativa successfully treated with infliximab and methotrexate.
De Souza A; Solomon GE; Strober BE
Bull NYU Hosp Jt Dis; 2011; 69(2):185-7. PubMed ID: 22035400
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment of SAPHO syndrome with zoledronic acid.
Kopterides P; Pikazis D; Koufos C
Arthritis Rheum; 2004 Sep; 50(9):2970-3. PubMed ID: 15457466
[TBL] [Abstract][Full Text] [Related]
18. SAPHO syndrome treated with pamidronate.
Tehrani R
Indian J Dermatol Venereol Leprol; 2005; 71(4):273-5. PubMed ID: 16394439
[TBL] [Abstract][Full Text] [Related]
19. Pamidronate treatment in SAPHO syndrome.
Guignard S; Job-Deslandre C; Sayag-Boukris V; Kahan A
Joint Bone Spine; 2002 Jun; 69(4):392-6. PubMed ID: 12184437
[TBL] [Abstract][Full Text] [Related]
20. [Diffuse sclerosing osteomyelitis of the mandible and SAPHO syndrome].
Fleuridas G; Teysseres N; Ragot JP; Chikhani L; Favre-Dauvergne E
Rev Stomatol Chir Maxillofac; 2002 Apr; 103(2):96-104. PubMed ID: 11997737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
